Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 4/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7059449 | 0.77 | ACHE (0.43) | CYP1A2CYP2A6PSMB5LMNATSHR | |
| SCHEMBL7185976 | 0.76 | CYP1A2 (0.38) | CYP1A2CYP2A6PSMB5FFAR4RAPGEF4 | |
| SCHEMBL5909751 | 0.74 | ACHE (0.41) | CYP1A2CYP2A6PSMB5LMNATSHR | |
| SCHEMBL28130112 | 0.74 | CYP1A2 (0.36) | CYP1A2CYP2A6PSMB5FFAR4LMNA | |
| Trimethylammonium SCHEMBL216520 | 0.73 | ALDH1A1 (0.39) | LMNATSHRALOX12ACHEALDH1A1 | |
| SCHEMBL8668539 | 0.73 | CYP1A2 (0.35) | CYP1A2CYP2A6PSMB5FFAR4LMNA | |
| SCHEMBL217204 | 0.72 | RAPGEF4 (0.47) | CYP1A2RAPGEF4 | |
| Trimethylammonium SCHEMBL27986158 | 0.71 | ALDH1A1 (0.37) | LMNATSHRALOX12ACHEALDH1A1 | |
| SCHEMBL134503 | 0.71 | ACHE (0.33) | PSMB5LMNATSHRALOX12ACHE | |
| SCHEMBL3126244 | 0.70 | CYP1A2 (0.33) | CYP1A2CYP2A6PSMB5FFAR4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1928 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114867758-B | Metallocene and method thereof | 埃克森美孚化学专利公司 | 2025-04-08 | — | — | CN | claimed |
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-19 | — | — | US | claimed |
| EP-4222180-A1 | BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-08-09 | — | — | EP | claimed |
| EP-4196507-A1 | CYCLIC CONTAINING POLYMER COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| US-11560441-B2 | Method for preparing polyolefin using supported hybrid metallocene catalyst | LG CHEM, LTD. | 2023-01-24 | — | — | US | claimed |
| EP-4103631-A1 | ETHYLENE-ALPHA-OLEFIN-DIENE MONOMER COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103629-A1 | POLYETHYLENE COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103628-A1 | PROPYLENE POLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103630-A1 | PROPYLENE COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4017887-A1 | ISOTACTIC PROPYLENE HOMOPOLYMERS AND COPOLYMERS PRODUCED WITH C1 SYMMETRIC METALLOCENE CATALYSTS | ExxonMobil Chemical Patents Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| US-20020103310-A1 | Catalyst composition, method of polymerization and polymer therefrom | UNIVATION TECHNOLOGIES, LLC | 2002-08-01 | — | — | US | claimed |
| US-20020103071-A1 | Catalyst composition and method of polymerization | UNIVATION TECHNOLOGIES, LLC | 2002-08-01 | — | — | US | claimed |
| WO-2002050127-A2 | START-UP PROCEDURE FOR MULTIPLE CATALYST POLYMERIZATION SYSTEMS | UNIVATION TECHNOLOGIES, LLC (US) | 2002-06-27 | — | — | WO | claimed |
| WO-2002046201-A1 | CATALYST COMPOSITION AND METHOD OF POLYMERIZATION | UNIVATION TECHNOLOGIES, LLC (US) | 2002-06-13 | — | — | WO | claimed |
| WO-2002046250-A2 | CATALYST COMPOSITION, METHOD OF POLYMERIZATION AND POLYMER THEREFROM | UNIVATION TECHNOLOGIES, LLC (US) | 2002-06-13 | — | — | WO | claimed |
| US-6362309-B1 | COORDINATION CATALYST | SYMYX TECHNOLOGIES, INC. | 2002-03-26 | — | — | US | claimed |
| WO-2002016681-A1 | POLYPROPYLENE FIBERS AND FABRICS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-02-28 | — | — | WO | claimed |
| WO-2000059961-A1 | POLYMERIZATION CATALYST LIGANDS, CATALYTIC METAL COMPLEXES AND COMPOSITIONS AND PROCESSES USING AND METHODS OF MAKING SAME | SYMYX TECHNOLOGIES, INC. (US) | 2000-10-12 | — | — | WO | claimed |
| EP-0418044-B1 | Metal complex compounds, process for preparation and method of use | DOW CHEMICAL CO (US) | 1997-09-10 | — | — | EP | claimed |
| EP-0765882-A2 | Metal complex compounds, process for preparation and method of use | THE DOW CHEMICAL COMPANY (US) | 1997-04-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | ODC1, DDT, OXGR1 | CYP1A2 746/4885CYP2A6 1945/4885PSMB5 4733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.